Nitrofurantoin detailed information

Jump to navigation Jump to search
Nitrofurantoin detailed information
Clinical data
Pregnancy
category
  • B
Routes of
administration
oral
ATC code
Legal status
Legal status
  • Rx, PoM
Pharmacokinetic data
Bioavailability40%
Metabolismliver (75%)
Elimination half-life20 minutes
Excretionurine and bile
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC8H6N4O5
Molar mass238.16

WikiDoc Resources for Nitrofurantoin detailed information

Articles

Most recent articles on Nitrofurantoin detailed information

Most cited articles on Nitrofurantoin detailed information

Review articles on Nitrofurantoin detailed information

Articles on Nitrofurantoin detailed information in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nitrofurantoin detailed information

Images of Nitrofurantoin detailed information

Photos of Nitrofurantoin detailed information

Podcasts & MP3s on Nitrofurantoin detailed information

Videos on Nitrofurantoin detailed information

Evidence Based Medicine

Cochrane Collaboration on Nitrofurantoin detailed information

Bandolier on Nitrofurantoin detailed information

TRIP on Nitrofurantoin detailed information

Clinical Trials

Ongoing Trials on Nitrofurantoin detailed information at Clinical Trials.gov

Trial results on Nitrofurantoin detailed information

Clinical Trials on Nitrofurantoin detailed information at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nitrofurantoin detailed information

NICE Guidance on Nitrofurantoin detailed information

NHS PRODIGY Guidance

FDA on Nitrofurantoin detailed information

CDC on Nitrofurantoin detailed information

Books

Books on Nitrofurantoin detailed information

News

Nitrofurantoin detailed information in the news

Be alerted to news on Nitrofurantoin detailed information

News trends on Nitrofurantoin detailed information

Commentary

Blogs on Nitrofurantoin detailed information

Definitions

Definitions of Nitrofurantoin detailed information

Patient Resources / Community

Patient resources on Nitrofurantoin detailed information

Discussion groups on Nitrofurantoin detailed information

Patient Handouts on Nitrofurantoin detailed information

Directions to Hospitals Treating Nitrofurantoin detailed information

Risk calculators and risk factors for Nitrofurantoin detailed information

Healthcare Provider Resources

Symptoms of Nitrofurantoin detailed information

Causes & Risk Factors for Nitrofurantoin detailed information

Diagnostic studies for Nitrofurantoin detailed information

Treatment of Nitrofurantoin detailed information

Continuing Medical Education (CME)

CME Programs on Nitrofurantoin detailed information

International

Nitrofurantoin detailed information en Espanol

Nitrofurantoin detailed information en Francais

Business

Nitrofurantoin detailed information in the Marketplace

Patents on Nitrofurantoin detailed information

Experimental / Informatics

List of terms related to Nitrofurantoin detailed information


Nitrofurantoin is an antibiotic. It is usually used in treating urinary tract infection. Like many other drugs, it is often used for killing E Coli.

Pharmacology

Organisms are said to be susceptible to nitrofurantoin if their Minimum inhibitory concentration (MIC) is 32μg/ml or less. The peak blood concentration of nitrofurantoin following an oral dose of nitrofurantoin 100mg, is less than 1 μg/ml and may be undetectable; tissue penetration is negligible; the drug is well concentrated in the urine: 75% of the dose is rapidly metabolised by the liver, but 25% of the dose is excreted in the urine unchanged, reliably achieving levels of 200 μg/ml or more. For this reason, nitrofurantoin cannot be used to treat anything other than simple cystitis.

At the concentrations achieved in urine, nitrofurantoin is bacteriocidal. The mechanism of action of nitrofurantoin is unique and complex. The drug works by damaging bacterial DNA, since its reduced form is highly reactive. This is made possible by the rapid reduction of nitrofurantoin inside the bacterial cell by flavoproteins (nitrofuran reductase) to multiple reactive intermediates that attack ribosomal proteins, DNA,[1] respiration, pyruvate metabolism and other macromolecules within the cell. It is not known which of the actions of nitrofurantoin is primarily responsible for its bacteriocidal acitivity.

Nitrofurantoin and the quinolone antibiotics are mutually antagonistic in vitro. It is not known whether this is of clinical significance, but the combination should be avoided.

Resistance to nitrofurantoin may be chromosomal or plasmid mediated and involves inhibition of nitrofuran reductase.[2] Acquired resistance in E. coli continues to be rare.

Nitrofurantoin and its metabolites are excreted mainly by the kidneys. In renal impairment, the concentration achieved in urine may be subtherapeutic. Nitrofurantoin should not be used in patients with a creatinine clearance of 60 ml/min or less.

Uses

The normal adult dose of nitrofurantoin is 50 to 100 mg four times daily for seven days. If a long-acting preparation (e.g., Macrobid) is used then the dose is 100mg twice daily. The pediatric dose is 3mg/kg/day in four divided doses. Nitrofurantoin should be taken with food, as this improves the absorption of the drug by 45%.

Nitrofurantoin is only clinically proven for use against E. coli or Staph. saprophyticus. It may also have in vitro activity against:

and is used in the treatment of infections caused by these organisms. Only a minority of Enterobacter species and Klebsiella species are sensitive to nitrofurantoin; nitrofurantoin has no activity against

Nitrofurantoin must never be used to treat pyelonephritis,[3] renal abscess, and pyeloempyema because of extremely poor tissue penetration and low blood levels. Urinary catheter infections may be treated with nitrofurantoin if there are no systemic features; the catheter must be changed after 48 hours of antibiotics and treatment is ineffective if the catheter is not replaced or removed.

Adverse effects

Nitrofurantoin can cause nausea and vomiting, fever, rash, hypersensitivity pneumonitis. When given for long periods of time, nitrofurantoin can cause progressive pulmonary interstitial fibrosis. All these side effects are much more common in the elderly.

Patients should be informed that nitrofurantoin colours urine a dark orange-brown; this is completely harmless.

Neonates (babies up to the age of one month) have immature enzyme systems in their red blood cells (glutathione instability) and nitrofurantoin must therefore not be used because it can cause haemolytic anaemia. For the same reason, nitrofurantoin should not be given to pregnant women after 38 weeks of pregnancy, or who are about to give birth.

Nitrofurantoin is contraindicated in patients with decreased renal function (CrCl < 60ml/min) due to systemic accumulation and subtherapeutic levels reached in the urinary tract.

Precautions

Nitrofurantoin must be taken with food and can cause bleeding in the stomach, vomiting and other gastrointestinal disruptions if these warnings are not adhered to. Nitrofurantoin is contraindicated in patients with glucose-6-phosphate dehydrogenase deficiency because of risk of extravascular hemolysis resulting in anemia.

Trade names

  • Furadantin (U.S., UK)
  • Macrobid (long acting preparation for twice daily dosing available in U.S., Canada, and UK)
  • Macrodantin (U.S., UK)
  • furatin( inda medica INDIA)

References

  1. Tu Y, McCalla DR (1975). "Effect of activated nitrofurans on DNA,". Biochem Biophys Acta. 402: 142&ndash, 49.
  2. McCalla DR, Kaiser C, Green MHL (1978). "Genetics of nitrofurazone resistance in Escherichia coli". J Bacteriol. 133: 10&ndash, 16.
  3. Richards WA; et al. (1955). "Nitrofurantoin: Clinical and laboratory studies in urinary tract infections". Arch Intern Med. 96: 437&ndash, 50.

Template:Other antibacterials


de:Nitrofurantoin fo:Nitrofuran hu:Nitrofurantoin

Template:WH Template:WS